Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Dermata Therapeutics Inc
DRMACurrent price
1.75 USD
-0.53 USD (-23.25%)
Last closed
2.06 USD
Company
www.dermatarx.com
ISIN
US2498451085
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 079 248 USD
Yield for 12 month
-89.58 %
1Y
3Y
5Y
10Y
15Y
DRMA
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Address: 3525 Del Mar Heights Road, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures DRMA
1 year
3 years
5 years
10 years
EBITDA
-7 856 542 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-90.68 %
PEG Ratio
–
Return On Equity TTM
-173.01 %
Wall Street Target Price
6 USD
Revenue TTM
–
Book Value
4.79 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-18.73 USD
Diluted Eps TTM
-18.73 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DRMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DRMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
16.05.2024
Dividend Date
–
Stock Valuation DRMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.5842
Price Book MRQ
0.6266
Financials DRMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DRMA
For 52 weeks
1.29 USD
17.25 USD
50 Day MA
2.02 USD
Shares Short Prior Month
45 080
200 Day MA
5.18 USD
Short Ratio
0.01
Shares Short
22 603
Short Percent
1.74 %
BeatStart